Major Ovarian Cancer Clinical Study Announced at Yale Using Combination Drug Therapy
Thomas Rutherford, M.D. A clinical study of ovarian cancer initiated by investigators at Yale School of Medicine will combine the anti-cancer drug phenoxodiol with docetaxel for women with recurrent ovarian cancer.
1 min read
